| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.016 | 0.8 |